Novartis Earnings Fall on Slide in Cancer-Drug Sales

Novartis said first-quarter earnings fell as the Swiss company plowed investment into new drug launches to offset a sharp dip in sales of the its blockbuster cancer medicine Gleevec.

from WSJ.com: US Business http://ift.tt/1r1ohrs
via IFTTT